ArticleJournal of translational medicine2025
Double vitrification-warming cycles coupled with one blastocyst biopsy do not affect the chance of live birth after an euploid blastocyst transfer: a propensity score matching study.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effects of chromosomal aneuploidy screening and secondary vitrification-warming on the pregnancy and neonatal outcomes of non-biopsied, previously vitrified embryos.
methodsThis retrospective cohort study included 963 single blastocyst transfer cycles between January 2018 and March 2023 that underwent one or two vitrification-warming and preimplantation genetic testing for aneuploidies (PGT-A). Propensity score matching was performed based on multiple baseline covariates, resulting in 351 conventional PGT-A cycles (single vitrification and single biopsy, SVSB group) and 197 thaw-biopsy-refreeze cycles (TBR group). MAIN OUTCOME MEASURE(S): The primary outcome was live birth rate, and secondary outcomes included biopsy parameters, clinical pregnancy outcomes, and neonatal outcomes.
resultsIn the matched samples, clinical baseline levels and biopsy results were essentially identical in the SVSB group and TBR groups. The live birth rate following PGT-A on remaining frozen embryos was comparable to that of standard PGT-A (40.2 vs. 46.7, p = 0.138). No statistically significant differences were found in other pregnancy outcomes or neonatal outcomes. No significant obstetric complications were observed in either group, and only one infant in the TBR group died at 15 days of age. CONCLUSION(S): Performing PGT-A with a second vitrification-warming cycle on remaining embryos does not adversely affect pregnancy or neonatal outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.